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Individuals with depression show depleted concentrations of the inhibitory neurotransmitter GABA in
occipital (visual) cortex, predicting weakened inhibition within their visual systems. Yet, visual inhibition
in depression remains largely unexplored. To fill this gap, we examined the inhibitory process of center-
surround suppression (CSS) of visual motion in depressed individuals. Perceptual performance in dis-
criminating the direction of motion was measured as a function of stimulus presentation time and
contrast in depressed individuals (n¼27) and controls (n¼22). CSS was operationalized as the accuracy
difference between conditions using large (7.5°) and small (1.5°) grating stimuli. Both depressed and
control participants displayed the expected advantage in accuracy for small stimuli at high contrast. A
significant interaction emerged between subject group, contrast level and presentation time, indicating
that alterations of CSS in depression were modulated by stimulus conditions. At high contrast, depressed
individuals showed significantly greater CSS than controls at the 66 ms presentation time (where the
effect peaked in both groups). The results' specificity and dependence on stimulus features such as
contrast, size and presentation time suggest that they arise from changes in early visual processing, and
are not the results of a generalized deficit or cognitive bias.
& 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Perceptual changes in depression represent an understudied
and promising area, one that lends itself to addressing a major
shortcoming of research on this mood disorder. While progress
has been made in understanding major depression at both biolo-
gical and psychological levels (Sanacora et al., 1999; Kircanski
et al., 2012; Belzung et al., 2014; Treadway and Pizzagalli, 2014)
there is often a disconnect between biological and behavioral le-
vels of analysis–in part due to the complexity of the phenomena
being studied. From a neurobiological perspective, perceptual
changes are simpler, and better understood. The visual system in
particular may be used as a model to study altered brain function
in depression at both levels. Basic perceptual processing deficits,
including non-affective stimuli, have been shown in currently and
formerly depressed individuals (Golomb et al., 2009; Bubl et al.,
2010). In addition, perceptual changes may be important factors in
the etiology and maintenance of major depression. For example,
depressed individuals gaze disproportionately more at dysphoricrved.
arlestown, MA 02129, USA.
rton).stimuli and less at positive stimuli during free viewing or search
tasks (Armstrong & Olatunji, 2012).
The present study represents an effort to understand functional
consequences of brain changes in depression at a perceptual level.
We studied a basic visual process in depression, specifically, an
inhibitory process within the visual motion system called center
surround suppression (CSS). CSS was chosen because depressed
individuals, as well as those who have recovered from depression,
show reduced concentrations of gamma-aminobutyric acid
(GABA) – the main inhibitory neurotransmitter – in the occipital
cortex (Sanacora et al., 1999; Bhagwagar et al., 2008). The estab-
lished GABA deficit in depression suggests that inhibitory pro-
cessing within the visual system might be altered, and perhaps
more specifically, weakened. Indeed, a previous study on CSS in
recovered depressed individuals showed reduced CSS of visual
motion in these individuals despite a lack of depressive symptoms
(Golomb et al., 2009), but data on currently depressed individuals
are not available. CSS is well understood at both the neurobiolo-
gical and perceptual levels (Born, 2000; Tadin et al., 2003), and
holds promise to shed light on how depression-associated brain
changes manifest at a perceptual level.
CSS refers to the organization of a neuron's receptive field, or
the area of visual space which, when stimulated, causes the
Fig. 1. Illustration of center-surround suppression. The inhibitory process occurs for a variety of stimuli processed in various parts of the visual system. Note that a larger
stimulus generates a smaller neural response and lower performance accuracy (i.e., perceptual response).
Table 1








Age 34.5 (14.8) 40.3 (12.4) T (47)¼1.49 0.14
Education 15.9 (2.1) 16.07 (2.2) T (47)¼0.23 0.82
Gender (M/F) 10/12 11/16 χ2 (1)¼0.11 0.74
WRAT* 49.3 (4.9) 50.4 (2.9) T (40)¼0.95 0.35
BDI-II** 0.59 (0.85) 29.6 (10.3) T (47)¼13.12 o0.001
* Wide Range Achievement Test Word Reading Score.
** Beck Depression Inventory – 2.
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221 215neuron to respond. If the center portion of the receptive field is
stimulated with light, the neuron's firing rate increases, and if the
area immediately surrounding this center portion is stimulated,
the neuron's firing rate decreases (Hubel and Wiesel, 1959; Born,
2000; Born and Bradley, 2005) (Fig. 1). This visual organization has
been well-studied at the cellular level in animals, and at the po-
pulation level in humans using transcranial magnetic stimulation
(TMS) and functional magnetic resonance imaging (fMRI) (Hubel
and Wiesel, 1968; Williams et al., 2003; Born and Bradley, 2005;
Sincich and Horton, 2005; Moutsiana et al., 2011; Tadin et al.,
2011). CSS has also been demonstrated psychophysically: as pre-
dicted by the neurobiological mechanisms at work, individuals
determine the direction of motion in a small object more easily
than in a large one, when both have high contrast (Tadin et al.,
2003).
CSS is hypothesized to be sensitive to GABA dysfunction, for
several reasons. First, GABA is the primary inhibitory neuro-
transmitter in the brain, and is thought to play a role in surround
suppression (Betts et al., 2005), which is an intrinsically inhibitory
process as described above. Second, administration of GABA an-
tagonists has been shown to modulate the size of the surround
portion of the receptive field (Pernberg et al., 1998; Murthy and
Humphrey, 1999). Third, individuals who have recovered from
depression, as well as individuals with schizophrenia, show both
depleted GABA levels in occipital cortex, and abnormalities in CSS
(Bhagwagar et al., 2008; Golomb et al., 2009; Yoon et al., 2010).
We investigated CSS within the motion processing system,
where GABA has been shown to play a key role in making cells
selective to direction of motion (Barlow et al., 1964; Grzywacz,
1997), in depression. We aimed to determine whether and how
depression is associated with altered inhibitory processing (oper-
ationalized using CSS) within the visual system. Based on a pre-
vious study in recovered-depressed individuals (Golomb et al.,
2009) and findings of diminished GABA levels in occipital cortex in
depression (Sanacora et al., 1999), we hypothesized that CSS would
be weakened in depressed individuals. Based on prior reports
(Churan et al., 2009), we further anticipated that CSS itself would
be present in both subject groups only at brief presentation times.2. Methods
2.1. Participants
Twenty-seven individuals with depression and 22 normal
controls participated in the study. Demographic and clinical
characteristics of the sample are provided in Table, 1. Depressed
participants were diagnosed using the Structured Clinical Inter-
view for DSM Disorders, 4th edition, (SCID-IV; First et al., (2002)),
and control participants were screened for Axis I disorders using
the non-patient version of the SCID (First et al., 2002). Twenty-twoof the depressed individuals met full criteria for a major depressive
episode at the time of the study, and five met criteria for a major
depressive episode in the last year and were in a state of partial
remission with significant residual clinical symptoms. Depression
levels at the time of testing were assessed using the Quick In-
ventory of Depressive Symptomatology (QIDS) and Beck Depres-
sion Inventory (BDI-II) (Beck et al., 1996; Rush et al., 2003). QIDS
data were missing for one depressed individual, and four controls,
to whom it was not administered.
None of the depressed participants had a co-morbid diagnosis
of any psychotic disorder. There was also no immediate family
history of psychotic disorders such as schizophrenia or bipolar
disorder with psychosis. Twelve of the depressed participants had
co-morbid Axis I disorders (eight anxiety disorders, three eating
disorders not including anorexia, and one PTSD), but depression
was their primary diagnosis. Eleven of the depressed participants
had a past but not current history of alcohol or substance abuse or
dependence. Thirteen of them were unmedicated, while 14 were
taking antidepressant medications. Of these, 6 were also taking an
anxiolytic, and 3 were taking an antipsychotic (aripiprazole) along
with a typical antidepressant to achieve autoreceptor activation.
The Wide Range Achievement Test (WRAT; Wilkinson (1993)) was
administered as a proxy of premorbid intellectual ability, though
this score was missing for 7 control subjects who were tested prior
to its adoption in the study protocol.
Twenty-two depressed individuals were recruited fromMcLean
Hospital outpatient and partial hospital clinics, while five de-
pressed individuals – as well as all control participants – were
recruited via advertisements in the greater Boston community. All
participants were fluent English speakers, with no history of
neurological diseases or head injuries with loss of consciousness
for more than one minute.
2.2. Stimulus and procedures
The stimulus was a drifting Gabor patch shown along with its
parameters in Fig. 2. Size and contrast of the stimulus remained
constant within a testing block; there were four blocks
Fig. 2. Gabor patches were either 1.5° (left panel) or 7.5° (right panel) in radius,
presented at one of two contrast levels, low or high, as described in the text. The
Gabor patches had a spatial frequency of 1 cycle per degree and drifted leftward or
rightward at 2°/sec.
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221216corresponding to the four combinations of size and contrast level.
For each block, there were 6 presentation times (17, 33, 66, 132,
264 and 528 ms), 2 directions (left and right) and 4 repetitions, for
a total of 48 trials. The stimulus characteristics are illustrated in
Fig. 2. The participants' task was to report the direction of motion
of the Gabor patch, left or right, by pressing the appropriate arrow
button on a standard computer keyboard. Stimuli were pro-
grammed using psychophysics toolbox and MatLab (Brainard,
1997) and were presented on one of two 21″ CRT monitors.
Twenty-two patients and 10 controls were tested on a Mitsubishi
Diamond Pro 2070 sb, mean luminance 47.3 cd/m2, which pre-
sented the low-contrast stimulus at 3.4% contrast, and the high
contrast stimulus at 75.1% contrast. The remaining 7 patients and
12 controls were tested on one of two Hewlitt Packard FP2141sb,
mean luminances of 58.4 and 56.2 cd/m2).The maximum contrast
values for these two monitors were 4% and 3.8% respectively for
the low contrast stimuli, and 81.8% and 79.2% respectively for the
high contrast stimuli. All three monitors operated at 120 Hz.
2.3. Data analysis
For each presentation time, performance accuracies were
averaged across 4 repetitions and the right and left directions (for
a total of 8 trials). Group differences in accuracy for each patch size
and contrast were analyzed using mixed model, 2-way analyses of
variance (ANOVA). Stimulus presentation time (17, 33, 66, 132, 264,
or 520 ms) was the within subjects variable, and group (Control or
Depressed) the between subjects variable. For all ANOVAs, if the
sphericity assumption was violated, the Huynh-Feldt correction
was applied.
The primary measure of CSS was the CSS index. This index was
derived by calculating the difference between the accuracies in the
small and large conditions, at each presentation time and contrast.
The main analysis on these data was a 3-way ANOVA with group
(between subjects), contrast and presentation time (within sub-
jects) as factors. In addition, secondary 2-way, mixed model AN-
OVAs were used to compare depressed and control participants on
CSS index at each contrast in their CSS index (across 6 presentation
times). The purpose of these secondary analyses was to follow up
on the general 3-way ANOVA and examine the nature of the ef-
fects at each contrast level.
Finally, for each participant, the thresholds for detection of the
direction of motion were calculated to determine the minimum
stimulus duration required to adequately perform the task at each
condition. These scores were calculated by fitting the data to a
Weibull function, which is expressed in the equation:
= − * ( )−y e1 .5 xa
b
where y is the proportion of trials judgedcorrectly, x equals the presentation time of the grating, and a and b
are two curve-fitting parameters (Norton et al., 2009). The
threshold was defined as the minimum presentation time where
the accuracy value of the function reached 80%. The purpose of
using this metric was for comparison with the previous study on
CSS in recovered-depressed individuals, where thresholds were
the primary dependent variable (Golomb et al., 2009).3. Results
3.1. Accuracy
Accuracy results are summarized in Fig. 3a. The results of AN-
OVA on these data are shown in Table 2.
At high contrast, control and depressed participants did not
differ when the Gabor patch was small. When the patch was large,
however, a significant interaction between presentation time and
group was found (Table 2), owing to lower accuracy at 66 ms in
depressed relative to healthy controls (t47¼4.02, po0.001). The
depressed group performed below chance accuracy in this condi-
tion (t26¼4.1, po0.001), with the modal response in the de-
pressed group being 25% accuracy.
At low contrast, groups did not differ for the large patch. For
the small patch, there was an interaction between group and
presentation time driven by depressed individuals' lower accuracy
at 66 ms (t47¼2.76, p¼0.008).
3.2. CSS index
Center-surround indices are summarized in Fig. 3b. The group x
presentation time x contrast level ANOVA on the CSS index re-
vealed a significant triple interaction (F3.6, 171.7¼4.88, p¼0.001,
η2¼0.09), indicating that the inhibitory process was modulated in
a different way across time and contrast levels in depressed in-
dividuals as compared to healthy individuals. Main effects were
significant for contrast (F1,47¼6.98, p¼0.011, η2¼0.13) and pre-
sentation time (F4.1, 193.3¼11.14, po0.001, η2¼0.19), but not for
group (F1,47¼0.39, p¼ .54, η2¼0.01). No other interactions were
significant (between contrast and group (F1,47¼2.68, p¼0.11,
η2¼0.05); between contrast and presentation time (F3.7,
171.7¼1.35, p¼0.26, η2¼0.03); and between presentation time and
group: F4.1, 193.3¼0.35, p¼0.85, η2¼0.01). Depressed individuals
with and without comorbid Axis I diagnoses did not differ from
each other on any of the effects (p40.05).
To unpack the three-way interaction, a separate ANOVA was
performed on the CSS index at low and high contrasts. The results
from these analyses are shown in Table 2. At high contrast, de-
pressed individuals showed greater CSS index scores than the
control group at intermediate presentation times, especially at
66 ms (t47¼3.39, p¼0.001). At low contrast, depressed individuals
CS index scores were non-significantly lower than controls at 66
msec (Fig. 3b, t47¼1.53, p¼0.13).
3.3. Medication effects
In order to determine whether the results above derive in part
from medication effects, we analyzed the depressed participants
who were not taking any medications separately and compared
them to the control group on three key analyses. Repeating the
main analysis on the CSS index with only the unmedicated de-
pressed individuals (n¼13), the three-way interaction remained
significant (F3.4,114.3¼5.19, p¼0.001, η2¼0.14). Repeating follow-
up ANOVAs with just the unmedicated depressed individuals
yielded the following results: for the high contrast condition, there
was a trend toward an interaction between group and
Fig. 3. A. Accuracy data on motion direction discrimination task under small, large, low and high contrast conditions (as labeled). Depressed participants differed sig-
nificantly from controls on the large, high contrast condition, and the small, low contrast condition. B. Center Surround Suppression (CSS) Index for low and high contrast
conditions. Stimulus duration modulated the CSS effect in both conditions, and there was a significant interaction between group and stimulus duration in the high contrast
condition. C. CSS Index for depressed individuals taking antidepressant and/or anxiolytic medications and not. Main effect of medication status, and its interaction with
presentation time were both significant.
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221 217presentation time (F3.5, 5.5¼2.23, p¼0.067). The main effect was
significant for presentation time (F5¼6.29, po0.001), but not for
group (F1¼0.04, p¼0.85). For low contrast, the interaction was
significant (F3.5, 115.1¼3.31, p¼0.018). The effect of group wassignificant (F1,33¼5.02, p¼0.032), with depressed individuals
showing lower CSS scores than controls, but the effect of pre-
sentation time was not (F3.15, 114.1¼1.22, p¼0.31).
Results of a comparison between depressed individuals taking
Table 2








F3.88, 182.3¼100.38 F1,47¼0.012 F3.88, 182.3¼0.44
po0.001, p¼0.91 p¼0.77
η2¼0.68 η2¼0.00 η2¼0.01
Large, high contrast F4.1, 194.8¼98.94 F1, 47¼3.36 F4.1, 194.8¼4.42
po0.001 p¼0.07, p¼0.002
η2¼0.68 η2¼0.07 η2¼0.09
Small, low contrast F3.4, 158.2¼165.27 F1, 47¼ .67 F3.4, 158.2¼2.95
po0.001 p¼0.41 p¼0.029
η2¼0.78 η2¼0.01 η2 ¼0.06
Small, high contrast F3.4, 159.1¼185.09 F1, 47¼0.13 F3.4, 159.1¼0.29
po0.001 p¼0.72 p¼0.86
η2¼ 0.80 η2¼0.00 η2¼0.01
CSS index low contrast F3.7,172.63¼3.27 F1, 47¼0.09 F3.7,172.6¼1.51
p¼0.016 p¼0.77 p¼0.21
η2¼0.07 η2¼0.00 η2¼0.03
CSS Index F4.2, 200.0¼9.71 F1, 47¼1.80 F4.2, 200.0¼3.17
high contrast po0.001 p¼0.18 p¼0.013
η2¼0.17 η2¼0.04 η2¼0.06
Fig. 4. A. Motion direction discrimination performance as a function of stimulus
contrast and size, quantified by duration threshold (minimum durations for which
performances reach the 80% correct level). B. Relation between CSS index at high
contrast and depressive symptoms (total score on Beck Depression Inventory II).
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221218medications and not taking medications are shown in Fig. 3c. The
comparison yielded the following results: At high contrast, the
effect of presentation time was significant (F4.4¼10.51, po0.001)
but the effect of medication status was not (F1,¼4.19, p¼0.051),
nor was the interaction between the two (F1¼0.29, p¼0.90). At
low contrast the effect of presentation time was not significant
(F3.7¼0.56, p¼0.68), but the effect of medication status was
(F1¼15.4, p¼0.001), as was the interaction between the two
(F1,3.7¼3.37, p¼0.007).
3.4. Threshold analysis
Threshold data are shown in Fig. 4a. The threshold data were
first analyzed using a three-way ANOVA between group, contrast
and size, which revealed main effects for size (F22.1,47¼22.2,
po0.001, η2¼0.32), contrast (F1,47¼42.1, po0.001, η2¼0.47), but
not for group (F1,47¼1.18, p¼0.28, η2¼0.03). The only significant
interaction was that between contrast and size (F1,47¼11.6,
p¼0.001, η2¼0.20). We then conducted two follow-up ANOVAs,
one at each contrast level, using stimulus size (within subjects)
and group (between subjects) as the independent variables, and
threshold as the dependent variable. For the high contrast, there
was a significant effect of size (F1,47¼26.47, po0.001), but not of
group (F1,47¼0.64, p¼0.43, η2¼0.01), and there was no size by
group interaction (F1,47¼0.13, p¼0.72, η2¼0.00). For the low
contrast, there was a significant effect of size (F1,47¼8.9, p¼0.004,
η2¼0.16, but there was no effect for group (F1,47¼1.49, p¼0.22,
η2¼0.03), nor was there a size by group interaction (F1,47¼0.07,
p¼0.79, η2¼0.00).
3.5. Relation between CSS and depressive symptoms
For these correlational analyses, we used the CSS index score at
66msec, where depressed individuals and control participants
differed the most. When including all participants, a positive
correlation was found between BDI score and the CSS index for the
high contrast condition (ρ49¼0.44 p¼0.001) (however, thecorrelation was not significant when including only the depressed
participants (ρ27¼0.30, p¼0.13) (Fig. 4b), but not for the low
contrast condition (ρ49¼0.10, p¼0.50). The high and low con-
trast correlations with the BDI differed significantly using Steiger's
Z test (Z46¼2.76, p¼0.006). Using the QIDS total yielded similar
results (high contrast: ρ44¼0.43, po0.01; low contrast:
ρ44¼0.03, p¼0.86). These two correlations also differed sig-
nificantly (Z41¼2.36, p¼0.02).4. Discussion
This study found that an inhibitory perceptual process, CSS of
visual motion, is altered in currently depressed individuals. The
nature of this alteration is sensitive to stimulus factors such as
contrast and presentation time (as shown by the triple interaction
between group, contrast and presentation time for the CSS index).
Contrary to our original hypothesis, depressed participants
showed greater CSS than controls at high contrast, as evinced by
decreased (significantly-below-chance) accuracy in the high con-
trast condition at the 66 msec presentation time. Presumably this
reduced accuracy in the depressed group is due to CSS. What is
happening in depressed individuals in this condition may be a
visual effect where the suppressive signal from the surround
portion of the stimulus actually overpowers the signal from the
center, which normally provides the basis for perceptual decisions.
For example, in a rightward stimulus, the rightward signal from
the center is suppressed so strongly by the surround that the
baseline activity of leftward direction neurons outweighs the
rightward signal, and forms a basis for perceived direction.
This decrease in accuracy translated to an increase in the CSS
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221 219index because depressed individuals showed normal performance
on the small high contrast stimulus (consistent with previous
studies that found normal performance in depressed individuals
on visual tasks; Wesner and Tan, 2006; Zomet et al., 2008). At
lower contrast, depressed individuals showed a trend toward re-
duced CSS, which became significant when including only the
unmedicated group. The magnitude of the CSS effect in both
groups and its alteration in the depressed group were dependent
upon the stimulus presentation time, both peaking at 66 ms
(Fig. 3). The specific alteration of this inhibitory process appears to
reflect a specific pathophysiological effect in the visual system of
depressed individuals, which has not been described before. In
light of these findings, and of the correlation between CSS and
symptoms (Fig. 4b), future studies should evaluate whether the
current paradigm could be used as a biomarker of depression or to
predict treatment response.
4.1. Altered CSS and the implications of inhibitory neurotransmission
The present results of increased CSS in depression are sur-
prising in light of the previous finding that depressed individuals
have decreased levels of GABA in occipital cortex overall (Sanacora
et al., 1999; Bhagwagar et al., 2007). If GABA is reduced in the
occipital cortex in depression, why would inhibition of a visual
process be increased, as we found in the high-contrast condition?
There are two potential explanations for this. The first is that the
concentration of GABA may not dictate the strength of inhibition
at a functional level. As no study has investigated GABA levels and
CSS in the same individuals, this interpretation awaits further
testing. In line with this suggestion though, a recent study showed
normal GABA concentration levels yet reduced visual evoked po-
tential in the occipital cortex of remitted depressive individuals
(Shaw et al., 2013). A second explanation is that GABA levels are
not actually depleted in the areas critical for this task and per-
ceptual effect. In addition to primary visual cortex, area MT in
extra-striate cortex is also critical for the performance of this task
(Huk and Heeger, 2000; Tadin et al., 2011). While GABA has been
shown to be depleted in the portion of occipital cortex that has
been sampled in depression, it may not be uniformly depleted, and
perhaps could even be increased in some areas. It is unknown
whether GABA in depression is depleted, heightened or normal in
area MT.
The results comparing medicated and non-medicated de-
pressed individuals in the present study are also interesting to
consider. At high contrast, the medicated and non-medicated de-
pressed individuals differed marginally, and at low contrast they
differed starkly. At low contrast, the unmedicated group displayed
essentially no CS effect whereas the medicated group showed a
strong one (Fig. 3c), on the order of what is seen in the control
group (Fig. 3b). This presence of a normal CSS index at low con-
trast in the medicated group derives from their lower accuracy in
the large 3% contrast condition. Despite the medicated subgroup's
lower accuracy on the large 3% contrast stimulus, one interpreta-
tion of the result-pattern would be that the medications normalize
the inhibition effect that should be present in the depressed in-
dividuals, but which is absent at low contrast. This result is con-
sistent with the closer-to-normal PERG contrast gain slopes in the
medicated group in another study on visual functioning in de-
pression (Bubl et al., 2010).
The co-occurrence of weakened and heightened CSS during
visual motion perception has been reported in patients with
schizophrenia, who showed increased surround suppression for
global motion stimuli (Chen et al., 2008), and decreased surround
suppression for local motion stimuli like the ones used in the
present study (Tadin et al., 2006). Contextual effects of sur-
rounding contrast upon a central stimulus have also been shownto be weakened in this patient group (Yang et al., 2013). Like de-
pression, schizophrenia also implicates GABAergic processes
(Benes 2000). However, the effects of contrast and presentation
time upon CSS of motion have not been studied in schizophrenia
in a systematic way. It will be useful to determine whether sti-
mulus-condition-dependent dysregulation of inhibitory process
may be a plausible mechanism for abnormal visual processing
across multiple psychiatric disorders.
4.2. Comparison of CSS between depressed individuals and those in
remitted depression
The present results stand in contrast to those from a previous
study by Golomb et al. (2009). At high contrast, Golomb et al.
found weakened CSS in non-depressed individuals who had re-
covered from previous depressive episodes. The present study
found heightened CSS in currently depressed individuals. There
are two potential, not mutually exclusive, explanations for the
discrepancy.
One explanation is that the visual inhibition for high contrast
stimuli substantially changes depending on depressed state (from
down-regulated to up-regulated, as depression goes from remitted
to acute state). The significant correlation between the QIDS/BDI
depression index and CSS in this study, and opposite directions of
CSS alteration in Golomb et al. and the present study, are both
consistent with this possibility.
Another explanation is that the spatial and temporal char-
acteristics of the stimuli differed between the two studies. The
present study systematically varied presentation time, allowing
the dynamic temporal profile of the CSS effect to be revealed in
depressed individuals (and in control participants). Heightened
CSS was found only around the 66 ms stimulus presentation time
and diminished at presentation times at and beyond 132 ms. The
study by Golomb et al. used a QUEST staircase procedure (Watson
and Pelli, 1983), which does not allow comparison of performance
at particular presentation times across subjects. Overall though,
the average threshold in that study was longer than 66 ms,
meaning that the CSS effects were generally acquired at longer
presentation times (around 150 ms for the large, high contrast
stimulus). It is unknown what Golomb and colleagues would have
found had they systematically collected data on large, high con-
trast stimuli in the vicinity of 66 msec. The dependence of the
effect on temporal factors of the stimulus underscores the like-
lihood that it arises from early visual processing areas in the brain,
rather than higher order cognitive areas.
Both the present study and Golomb et al. found deficient per-
formance in the depressed group at low contrast in the small
stimulus condition. This is the condition where motion signals are
the weakest, and therefore it may be the most sensitive to uncover
problems in detecting the direction of motion, regardless of CSS
processes which should not have significant influence in this
condition. Since computing the direction of motion also involves
GABAergic processing (Thiele et al., 2004), it may be that GABA
depletion is responsible for the poor ability to discriminate di-
rection of motion in the small low contrast condition.
4.3. Limitations and future directions
The present study had a limited sample size. If the results are
replicated, the paradigm used here will be a powerful one for
measuring inhibitory processing at a functional level in depression
and other disorders. Moreover, a systematic study of the effect of
antidepressant and anxiolytic medication on visual motion in-
hibition would be informative, though the main result of this study
(3-way interaction between group, contrast and presentation
time) remained significant when only including unmedicated
D.J. Norton et al. / Psychiatry Research 240 (2016) 214–221220depressed individuals. Therefore, the result seems to be intrinsic to
depression itself, not medication status. In magnetic resonance
spectroscopy studies, antidepressant medications have been
shown to increase GABA levels in depressed individuals (Sanacora
et al., 2002, 2006), whereas cognitive behavioral therapy appears
to decrease GABA levels in depressed individuals (Sanacora et al.,
2006). Both therapies are equally effective at mitigating depres-
sion, but apparently have very different effects upon neuro-
transmitter concentrations, raising the question of the effect that
these treatments might have upon motion processing in general
and CSS in particular. In order to strengthen the link between
biological and psychological levels of understanding of inhibitory
processing in depression, the present study should be repeated
while measuring GABA levels in the depressed individuals being
studied, perhaps while also administering GABAergic medications
to some participants.
Depressed individuals showed reduced accuracy in the high
contrast large condition, and the low contrast small condition. One
interpretation of this would be that these are the two most chal-
lenging conditions perceptually (faint and small, and high-inhibi-
tion due to CSS), and the altered performance in depressed in-
dividuals arose from a lack of concentration or general deficit on
these challenging conditions. However, this interpretation is pro-
blematic, since all four conditions involved difficult presentation
times which required subjects to guess on roughly half of the
trials. If extent of challenge were a factor in depressed individuals’
deficient accuracy, we would expect to see a consistent deficiency
in their performance on the difficult trials (short presentation
times) on each of the graphs in Fig. 3a, but this is not the case. The
specificity of the alterations in depression, and their dependence
on stimulus parameters suggest an abnormality in visual in-
hibitory process rather than a generalized perceptual or atten-
tional deficit.
The present study used stimuli which differed slightly from
previous ones (Tadin et al., 2003; Golomb et al., 2009). The small
stimuli were slightly larger, and the low-contrast stimuli had
slightly higher contrast than in previous studies. A second differ-
ence between ours and previous studies is that the original paper
by Tadin on CSS, as well as others that replicated it, used a pause of
1500 ms while viewing a flickering fixation cross, followed by a
500 ms blank screen before the stimulus was presented. After
stimulus presentation we showed a blank screen during subjects'
response, and kept the screen blank until the next stimulus was
presented, 1000 ms after the button press indicating the subject’s
answer. We made these adjustments for the sake of time, and
because we anticipated that larger, higher contrast stimuli would
be less discouraging and easier to concentrate on for depressed
participants. We did not anticipate that these spatial and temporal
changes would affect the results, based on the known patterns of
performance in healthy adults (Tadin et al. 2003). However, they
might have been responsible for the presence of a CSS effect in
healthy controls at low contrast in the present study. Interestingly,
this unexpected result in the control group allowed an interesting
effect to emerge in the depressed group namely that unmedicated
depressed individuals did not show CSS at low contrast, but
medicated depressed individuals did. Finally, the use of multiple
monitors may have potentially added noise to the data, and
therefore, the degree to which CS suppression occurred. The re-
sults for the high-contrast condition unlikely varied from monitor
to monitor here, since the CS suppression effect is robust across a
much wider range of contrasts than those we used for our high-
contrast stimulus (Tadin et al., 2003). Note that the main results of
the study, the three way interaction between contrast, presenta-
tion time and group for the CS effect, and the interaction between
group and presentation time at high contrast, remained significant
if the 12 controls and 5 patients tested on the HP monitors wereremoved from the analysis, suggesting that the main finding of
this study stands with use of a single monitor.
4.4. Conclusion
In combination with the results from Golomb et al. (2009), the
present results suggest that a basic visual inhibitory process, as
indexed by CSS, changes in a very pronounced way as individuals
fluctuate from the acutely depressed state (heightened CSS at high
contrast) to the recovered state (weakened CSS at high contrast). If
confirmed, CSS represents a promising state marker of depression,
which is unaffected by baseline (general) performance deficits
associated with this psychiatric disorder. The results suggest that
studying the visual system, particularly across perceptual condi-
tions with strong physiological correlates, in depression may be a
valuable endeavor.
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